Grants & Awards Programs

• 2026 LMI Pilot Award

  The Lymphatic Malformation Institute is accepting Letters of Intent for its Pilot Award 2026.

  This prestigious award, up to $75,000, supports a one-year exploratory research period, to develop and test exciting new hypotheses or research approaches that have the potential to significantly advance our understanding and/or treatment of Complex Lymphatic Anomalies which include Central Conducting Lymphatic Anomaly (CCLA), Generalized Lymphatic Anomaly (GLA), Gorham Stout Disease (GSD), or Kaposiform Lymphangiomatosis (KLA). Areas of interest include, but are not limited to, genetic analysis, biomarker identification, preclinical model development and characterization, imaging, and single-cell RNA sequencing of animal or patient samples.

  It’s imperative to note the following dates:

  1. March 20, 2026 - Submission deadline for the Letter of Intent. Please ensure your LOI is sent to grants@lmiresearch.org by 11:59 PM CST.

  2. May 29, 2026 - Final deadline for invited investigators to submit their full grant proposals. Submissions should reach the same email by 11:59 PM CST. The application, instructions, and required documents can be found on LMI’s website. For any queries or further assistance, feel free to contact Michael Dellinger, PhD, Associate Professor, UT Southwestern Medical Center, at mdellinger@lmiresearch.org or michael.dellinger@utsouthwestern.edu.

  Learn More >
• Patient-Centered Outcomes Research Institute

  About PCORI

  PCORI is the leading funder of patient-centered comparative clinical effectiveness research in the United States.
  The Patient-Centered Outcomes Research Institute (PCORI) is an independent, nonprofit research funding organization that seeks to empower patients and others with actionable information about their health and healthcare choices. 

  What We Do

  We fund patient-centered comparative clinical effectiveness research (CER) and research-related awards, issuing funding opportunity announcements several times each year.

  Funding Opportunities | PCORI

  Learn More >
• 
  Lymphatic researchers needed for NIH Study Sections

  LE&RN was asked to recruit and has registered through the CSR portal in order to recommend potential reviewers. They have identified the following three Study Sections that review lymphatic grant proposals:

  * Hypertension and Microcirculation (HM) Study Section reviews applications dealing with propulsion of lymph, lymphatic tone, and pathogenesis of lymphedema with more focus on functional studies; sometimes reviews applications about the lymphatic system in infection and inflammation depending on the outcome of research, namely whether focused on lymphatics or infection.
  
  
  * Immunity and Host Defense (IHD) and Innate Immunity and Inflammation (III) Study Sections may review applications that address lymphatic role in infection.
  
  
  * Cardiovascular Differentiation and Development (CDD) Study Section reviews applications involving lymphatic development, lymphangiogenesis, and lymphedema focusing on structure.

  If you are willing to serve on one or more of the above-identified NIH Study Sections, please contact LE&RN at LERN@LymphaticNetwork.org with the following information:

  * Name
  * Affiliation
  * Study Section(s) on which you are willing to serve
  * In 50 words or less, your qualifications for each Study Section selected
  * Include CV

  Investigators will not be able to review their own research or research on which they are collaborators. However, this will not prevent your research from being reviewed by the Study Section. Per NIH: If a researcher is on a Study Section and has an application, his or her application is reviewed by a special emphasis panel. This is a common practice that happens all the time. This should not be an obstacle to joining a Study Section.